首页|参苓白术散对脾虚湿困证高脂血症患者的临床疗效及对肠道菌群影响

参苓白术散对脾虚湿困证高脂血症患者的临床疗效及对肠道菌群影响

扫码查看
目的 研究参苓白术散对脾虚湿困证高脂血症患者的临床疗效,并探讨其作用机制与肠道菌群的相关性。方法 收集我院脾虚湿困证高脂血症患者60例,随机分为试验组和对照组,各30例。对照组患者采用阿托伐他汀治疗,试验组在此基础上加用参苓白术散治疗,疗程均为4周。通过血液检测和粪便检测观察两组患者干预前后的血脂指标水平、中医证候积分及肠道菌群变化情况。结果 两组患者治疗后血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、甘油三酯(TG)水平显著降低,血清高密度脂蛋白胆固醇(HDL-C)水平显著升高;试验组患者治疗效果优于对照组。两组患者治疗后中医证候积分均低于治疗前,且试验组低于对照组;试验组患者治疗后总有效率(93。33%)高于对照组(73。33%)。Alpha多样性和beta多样性分析发现,高脂血症脾虚湿困证患者肠道菌群的物种丰富度降低。治疗后试验组患者肠道菌群物种丰富度、多样性升高幅度均大于对照组(均P<0。05)。在肠道菌群结构上,两组患者治疗前后的差异较大。试验组患者治疗后放线菌门、厚壁菌门丰度显著降低,疣微菌门、变形菌门丰度显著升高;同时埃希-志贺菌属、克雷伯菌属、肠球菌属、阿克曼菌属丰度显著升高。试验组患者治疗后肠道柠檬酸杆菌属、肠杆菌属、摩根菌属、变形杆菌属的sqrtIVt值显著高于其他组,可以作为该组的潜在指示物种。结论 参苓白术散可有效改善脾虚湿困证高脂血症患者的血脂指标水平和中医证候表现,其作用机制与调节肠道菌群相关。
The effects of Shenling Baizhu Powder on clinical efficacy and intestinal flora in hyperlipidemia patients with spleen deficiency and dampness syndrome
Objective To observe the clinical effects of Shenling Baizhu Powder on hyperlipidemia patients with spleen deficiency and dampness syndrome,and explore the correlation between its mechanism of action and intestinal flora.Methods Sixty patients with hyperlipidemia due to spleen deficiency and dampness in our hospital were enrolled and randomly divided into the experimental group(n=30)and control group(n=30).Both groups were treated with Atorvastat-in,while the experimental group was treated with Shenling Baizhu Powder additionally,for 4 weeks.Blood tests and stool tests were used to observe the changes of blood lipid indexes,TCM syndrome scores and intestinal flora before and after intervention.Results After treatment,the serum levels of TC,TG and LDL-C significantly decreased in both groups of patients,while that of HDL-C significantly increased.The effect in the experimental group was better than in the control group.The TCM syndrome scores in both groups were lower after treatment,and that in the experimental group was lower than in the control group.The total efficiency rate in observation group was 93.33%,higher than the 73.33%in the control group.Alpha and beta diversity analysis revealed that the species richness of gut microbiota decreased in patients with hy-perlipidemia,spleen deficiency and dampness deficiency syndrome.After treatment,the experimental group showed a greater increase in species richness and diversity of gut microbiota compared to the control group(all P<0.05).In terms of intestinal flora structure,there were significant differences between the two groups before and after treatment.After treat-ment,the abundances of Firmicutes and Actinobacteria significantly decreased,while those of Proteobacteria and Verruco-mycota significantly increased in the experimental group;at the genus level,the abundances of Escherichia-Shigella,Kleb-siella,Enterococcus and Akkermansia significantly increased.Biomarker analysis revealed that the sqrtIVt values of Cit-robacter,Enterobacterium,Morganella and Proteobacterium in the experimental group were higher than those in the other groups after treatment,which could be used as potential indicator species for this group.Conclusion Shenling Baizhu Powder can effectively improve the blood lipid indexes and TCM syndromes of hyperlipidemia in spleen deficiency and dampness syndrome,and its mechanism is related to the regulation of intestinal flora.

Shenling Baizhu PowderIntestinal floraSyndrome of spleen deficiency and dampnessHyperlipidemiaClin-ical efficacy

尤金彪、董金敏、张斌、梁娣、肖英俊

展开 >

浙江中医药大学附属第三医院检验科,浙江 杭州 310000

参苓白术散 肠道菌群 脾虚湿困证 高脂血症 临床疗效

2024

中国微生态学杂志
中华预防医学会 大连医科大学

中国微生态学杂志

CSTPCD北大核心
影响因子:1.115
ISSN:1005-376X
年,卷(期):2024.36(11)